Effect of a Dietary Supplement Containing Raspberry Ketone onCytochrome P450 3A Activity

Objective: Various herbal medicines and dietary supplements are known to alter the effects of drugs and cause severe complications. One of the most famous examples is St. John’s wort, which promotes an increase of cytochrome P450 2C9 (CYP2C9), CYP2C19, and CYP3A4 expression, and reduces the effects of a large number of drugs. Raspberry ketone, an aromatic ingredient extracted from raspberries, is sold in Japan as a herbal supplement with a claimed slimming effect; however, its effect on CYP activity is unknown. To clarify the risk of an interaction between raspberry ketone-related supplements and CYP3A substrates, we performed an in vivo pharmacokinetic study using rats. Methods: We investigated the effect of the oral administration of raspberry ketone on the pharmacokinetics of midazolam, a typical CYP3A substrate, in rats. St. John’s wort, as a positive control, and raspberry ketone tablets at a dose of 50 mg/kg were administered every 12 h for 7 days, and at 24 h after the final treatment, 10 mg/kg midazolam was administered orally. The plasma concentration of midazolam was analyzed by high-performance liquid chromatography. Results: Oral clearance of midazolam in the St. John’s wort-treated group increased to 161% of that observed in the control group. Conversely, there was no significant difference between the raspberry ketone-treated and control groups. The mean residence time was essentially the same in all groups. Conclusion: Because raspberry ketone is considered to suppress the accumulation of body fat, it is mainly taken by young healthy women for weight loss. Considering this population, information about the interaction of raspberry ketone with oral contraceptives, which are substrates of CYP3A, is of clinical importance. In this study, raspberry ketone was found to have little impact on CYP3A activity, unlike St. John’s wort. These data indicate the low risk of an interaction between raspberry ketone-related supplements and many drugs metabolized by CYP3A.

[1]  Xue-jia Zhai,et al.  Capsaicin pretreatment increased the bioavailability of cyclosporin in rats: involvement of P-glycoprotein and CYP 3A inhibition. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  K. Bley,et al.  Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicin , 2010, Xenobiotica; the fate of foreign compounds in biological systems.

[3]  B. Bernard,et al.  Studies of the Toxicological Potential of Capsinoids, XIII: Inhibitory Effects of Capsaicin and Capsinoids on Cytochrome P450 3A4 in Human Liver Microsomes , 2010, International journal of toxicology.

[4]  P. Ambrose,et al.  Drug interaction between oral contraceptives and St. John's Wort: appropriateness of advice received from community pharmacists and health food store clerks. , 2007, Journal of the American Pharmacists Association : JAPhA.

[5]  Koujirou Yamamoto,et al.  Time-dependent induction of midazolam-1-hydroxylation enzymes in rats treated with St. John's wort. , 2005, Biological & pharmaceutical bulletin.

[6]  T. Tsujita,et al.  Anti-obese action of raspberry ketone. , 2005, Life sciences.

[7]  R. Day,et al.  Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. , 2004, British journal of clinical pharmacology.

[8]  Honghao Zhou,et al.  St John's wort induces both cytochrome P450 3A4–catalyzed sulfoxidation and 2C19–dependent hydroxylation of omeprazole , 2004, Clinical pharmacology and therapeutics.

[9]  W. Kirch,et al.  Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. , 2008, British journal of clinical pharmacology.

[10]  Shiew-Mei Huang,et al.  The interaction between St John's wort and an oral contraceptive , 2003, Clinical pharmacology and therapeutics.

[11]  R. Kim,et al.  Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects , 2003, Clinical pharmacology and therapeutics.

[12]  A. Fujimura,et al.  Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin , 2001, Clinical pharmacology and therapeutics.

[13]  P. Smet,et al.  Safety of St John's wort (Hypericum perforatum) , 2000, The Lancet.

[14]  Q. Yue,et al.  Safety of St John's wort (Hypericum perforatum) , 2000, The Lancet.

[15]  A. Kobayashi,et al.  Capsaicin activates heat loss and heat production simultaneously and independently in rats. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[16]  T. Kawada,et al.  Effects of capsaicin analogs on adrenal catecholamine secretion in rats. , 1994, Life sciences.

[17]  R. Teel,et al.  Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. , 1993, Anticancer research.

[18]  K. Hagihara,et al.  Effects of capsaicin on lipid metabolism in rats fed a high fat diet. , 1986, The Journal of nutrition.

[19]  R. Scheline,et al.  The metabolism of 4-(4-hydroxyphenyl)butan-2-one (raspberry ketone) in rats, guinea-pigs and rabbits. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.